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in Monte Negro reached 30% of total health expences during 2003, informational system (IS) in outpatient health practice was introduced. This system enabled the total control and follow up in area of use of drugs covered financially by the health fund. METHODS: IS bind together pharmacies, health care institutions, databases of persons with health insurance, drugs, and health care providers. Through unique code system automatic information flow imported through bar code was enabled.
RESULTS:
In the first year after introduction of IS (2004) Centre of Pharmacoeconomics, University of Milan, Milan, Italy A very difficult objective to be reached in the field of outcome research is to measure Quality of Life (QoL) in paediatric populations. Non negligible semantic ambiguity has been shown to characterize health perceptions and descriptions in developmental age. OBJECTIVE: As a part of the project aimed at developing a valid and reliable Italian version of EQ-5D suitable for children-i.e. the Italian Child-Fiendly EQ-5D (CF-EQ-5D) project-statistically based lexical analyses are applied. The aim of the analyses is to identify the semantic field associated to each item of the instrument, with the final purpose of formulating comprehensible, valid, unambiguous, and reliable items in Italian CF-EQ-5D. METHODS: Thirty children/adolescents (aged 8-15 years, all native speakers, resident in different parts of Italy), gave their informed consent and self-completed an Italian version of CF-EQ-5D (from a forward-backward-forward translation method). Then participants were submitted to face-to-face and tape-recorded cognitive interviews and were invited to generate word associations in response to the core words of each item. RESULTS: The resulting textual corpus (normalized and lexicalized) is submitted to descriptive and multivariate statistical analyses fit for textual data. An analysis of lexical specificity is calculated in order to illustrate the general features of the vocabulary generated by respondents. In a second step, Multiple Correspondence Analysis is performed on a words*contexts matrix, with socio-demographic characteristics of the participants as illustrative variables. CONCLUSIONS: Preliminary outcomes suggest that children and adolescents associate non-univocal semantic fields to core aspects of the health-related lexicon. Implications for the developing and improving of the Italian Child-Friendly version of EQ-5D will be discussed to realize the final version of the questionnaire. There is a lack of a validated QoL questionnaire assessing the psychological burden and treatment benefits of bedwetting as evaluated by the child. This abstract reports the results of the initial validation tests for such a questionnaire. It is being developed in accordance with the validation standards of the ICIQ. METHODS: A literature review was conducted and led to quantitative interviews with 28 children suffering from Nocturnal Enuresis and 28 pairs of parents. Consequently a questionnaire including 20 questions was developed and tested in a multinational Randomised Clinical Trial completed by 196 children and 196 parents in antidiuretic treatment before and during the trial. RESULTS: Based on review and interviews, a list of issues was identified: Social isolation, emotional distress, low self-esteem, problems in parent-child relation, delayed independence and fear of being teased at school and home. Two or more questions were developed for each of the six issues to add room for elimination of poorly performing questions. The RCT data indicated promising cluster effect, i.e. the well treated children showed a high QoL, and the questions seemed test-retest consistent. Some questions yield a high level of missing answers.
PIH15 DEVELOPMENT OF AN ICIQ NOCTURNAL ENURESIS QOL QUESTIONNAIRE

CONCLUSION:
The tests led to reformulation of the questions yielding missing answers and the questionnaire is now ready for the coming validation, including sensitivity analysis and item reduction. We are convinced that future research in Nocturnal Enuresis will profit from the final questionnaire.
PIH16 TREATMENT DURATION FOR ATROPHIC VAGINITIS: CLINICAL TRIALS VERSUS "THE REAL WORLD"
Balu S Adults initiating VET between January and June, 2004 in 57 managed care plans (PharMetrics database) in the United States were identified and followed for up to 10 months to examine their treatment duration. A Kaplan-Meier analysis was performed to obtain average and median time to discontinuation for individuals treated with VT or VC. A weighted average of treatment duration was calculated for a total of seven clinical trials identified in the literature. These results were stratified by study inclusion criteria. Differences in average treatment duaration were statistically tested using t-tests. RESULTS: Of 5599 patients undergoing VET (mean age = 54 ± 9.1 years), 4355 (77.8%) received VC and 1244 (22.2%) received VT. Patients prescribed VT had a significantly longer average (median) treatment compared to patients prescribed VC [(198.5 ± 82 .4 days (221 days) vs. 177.1 ± 86.7 days (190 days)); p < 0.01)]. This duration in clinical practice was significantly longer than that in seven clinical trials [165 days (240 days for three trials of both VC and VT; 90 days for two VT-only studies; and 69 days for two VC-only studies)]. CONCLUSIONS: Duration of VET was longer in a real-world clinical practice setting than in clinical trials. Moreover, subjects treated with VT exhibited significantly longer treatment duration than subjects treated with VC. Possible factors explaining longer duration with VT include ease of use, reduced messiness, accurate dosing resulting in improved effectiveness and fewer adverse events, and consequently improved quality of life. Future studies should prospectively examine factors associated with these differences.
PIH17 ASSESSING PSYCHOLOGICAL BURDEN AND TREATMENT BENEFITS IN PEDIATRIC PATIENTS WITH BEDWETTING
Weinstein D 1 , Sendersky V 1 , Holm-Larsen T 2 , Nørgaard JP 1 1 Ferring Pharmaceuticals, Copenhagen, Denmark, 2 University of Pharmaceutical Sciences, Copenhagen, Denmark OBJECTIVES: Nocturnal enuresis (NE) can pose significant psychological burden on children's self-esteem and quality of life (QoL). Therefore, patient-reported outcome (PRO) measurement is essential to fully understand the burden posed by NE and the benefits of treating this condition. To our knowledge, it has not been investigated which instruments should be used to assess the psychological burden of NE. The aim of this study was to identify and evaluate PRO instruments used in children with NE. METHODS: A literature search of Medline and other databases was conducted to identify publications from 1995-2006 which contained PRO instruments used in children with NE. RESULTS: 40 studies and 32 PRO instruments were identified. Instruments were evaluated based on psychometric properties and responsiveness to change. Some studies used several PRO instruments. The Child Behavior Checklist was the most commonly used instrument (8/40 studies, 20%). Measures of self-esteem were used in 11/40 studies (28%). No generic QoL measures were used in these trials. No disease-specific PRO instruments were found to be fully validated in the NE. population. Currently, a new disease-specific QoL questionnaire is in development for NE. CONCLUSIONS: The results of this study highlight the lack of patient-reported disease-specific PRO measures to assess the burden and treatment benefits of NE. A new disease-specific instrument may be able to fill this gap. To compare Finnish patients with erectile dysfunction (ED) and men from the Finnish general population in measures of self-reported Health-Related QOL (HRQoL) and satisfaction with life, and to investigate whether switching patients from current oral ED medication to tadalafil impacts these measures. METHODS: A total of 202 Finnish men over 18 years successfully treated with oral ED prescription medication (tadalafil excluded) voluntarily entered this multicenter, open-label, one-arm, 3-month study. Upon enrollment, patients discontinued their previous therapy and were started on tadalafil 10 or 20 mg (dose determined by investigator) on demand. Outcome was measured using the 15D and Life Satisfaction-11 (LiSat-11) checklists. 15D is a generic, comprehensive, 15-dimensional, standardized, self-administered measure of HRQoL
PIH18 DIMENSIONS OF HRQOL AND SATISFACTION WITH LIFE IMPROVE IN ED PATIENTS SWITCHING FROM OTHER ORAL ED MEDICATION TO TADALAFIL
